Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

187

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
M04AA01	ALLOPURINOL BIOGARAN	G	Allopurinol - 200mg	200mg	Tablet	169,324 L.L
M04AA01	ZYLORIC	B	Allopurinol - 300mg	300mg	Tablet	302,365 L.L
M04AA01	ALLOPURINOL BIOGARAN	G	Allopurinol - 300mg	300mg	Tablet	212,327 L.L
M04AA01	ALURIC	G	Allopurinol - 300mg	300mg	Tablet, scored	175,339 L.L
M04AA01	APO-ALLOPURINOL	G	Allopurinol - 300mg	300mg	Tablet	626,231 L.L
N02CC05	ALMOVITAE	G	Almotriptan - 12.5mg	12.5mg	Tablet, film coated	1,148,985 L.L
A10BH04	VIPIDIA	B	Alogliptin benzoate - 25mg	25mg	Tablet, film coated	2,998,113 L.L
L01EM03	PIQRAY	B	Alpelisib - 150mg	150mg	Tablet, film coated	359,195,954 L.L
L01EM03	PIQRAY	B	Alpelisib - 200mg, Alpelisib - 50mg	150mg	Tablet, film coated	359,195,954 L.L
R02A	MAXILASE MAUX DE GORGE	B	Alpha-Amylase - 200U.CEIP/ml	200U.CEIP/ml	Syrup	342,680 L.L
R02A	ALFA-AMYLASE BGR CONSEIL	G	Alpha-Amylase - 200U.CEIP/ml	200U.CEIP/ml	Syrup	384,339 L.L
R02A	ALFA-AMYLASE BGR CONSEIL	G	Alpha-Amylase - 3,000U.CEIP	3,000U.CEIP	Tablet, coated	290,270 L.L
N05BA12	ALPRAZOLAM BIOGARAN	G	Alprazolam - 0.25mg	0.25mg	Tablet, scored	115,570 L.L
N05BA12	XANAX	B	Alprazolam - 0.5mg	0.5mg	Tablet	477,064 L.L
N05BA12	ALPRAZOLAM BIOGARAN	G	Alprazolam - 0.5mg	0.5mg	Tablet, scored	169,324 L.L
N05BA12	ALPROX	G	Alprazolam - 0.5mg	0.5mg	Tablet	383,955 L.L
N05BA12	PAZOLAM	G	Alprazolam - 0.5mg	0.5mg	Tablet	563,070 L.L
N05BA12	TRANQUINAL 0.5	G	Alprazolam - 0.5mg	0.5mg	Tablet	267,425 L.L
N05BA12	TRANQUINAL 0.5 SUBLINGUAL	G	Alprazolam - 0.5mg	0.5mg	Tablet, sublingual	459,594 L.L
N05BA12	ALPROX	G	Alprazolam - 1mg	1mg	Tablet	895,895 L.L
C01EA01	PROSTIN VR	B	Alprostadil - 500mcg/ml	500mcg/ml	Injectable concentrated solution	19,894,577 L.L
B01AD02	ACTILYSE	BioTech	Alteplase - 50mg	50mg	Injectable dry powder for solution+diluent	100,976,426 L.L
A02AF02	ACTONORM	B	Aluminium hydroxide - 220mg/5ml, Magnesium hydroxide - 200mg/5ml, Simethicone - 25mg/5ml		Suspension	425,998 L.L
B03BA51	DEPOVEX	B	Aluminium monostearate - 20mg/ml, Cyanocobalamine - 1mg/ml		Injectable oily suspension	423,310 L.L
A03AX58	METEOSPASMYL	B	Alverine citrate - 60mg, Simethicone - 300mg		Capsule	481,096 L.L
N04BB01	PK-MERZ	B	Amantadine (sulfate) - 100mg	100mg	Tablet, film coated	1,382,814 L.L
N04BB01	SYMMETREL	B	Amantadine - 100mg	100mg	Capsule	568,253 L.L
R05CB06	FLUIBRON	G	Ambroxol - 15mg/5ml	15mg/5ml	Syrup	459,594 L.L
R05CB06	MUKORAL	G	Ambroxol - 30mg	30mg	Tablet	201,576 L.L
R05CB06	SOLVAMUC SR	G	Ambroxol - 75mg	75mg	Capsule	276,448 L.L

...

187